KILLING CANCER CELLS IN VITRO IS NOT ENOUGH

Can you anticipate the interplay between host animal and characteristics of the tumor model itself in immuno-oncology studies?

Scientists at MI Bioresearch have run close to 1,000 preclinical immuno-oncology studies over the past five years, thoughtfully evaluating all aspects of study design.

Read our guide to learn about:

  • Modeling immuno-oncology in mouse models
  • Maximizing tumor placement for stromal-tumor interactions
  • Selecting a tumor model to test a checkpoint inhibitor
  • Plus more!